NMDAR activation regulates the daily rhythms of sleep and mood

Jeffrey S. Burgdorf*, Martha H. Vitaterna, Christopher J. Olker, Eun Joo Song, Edward P. Christian, Laurits Sørensen, Fred W. Turek, Torsten M. Madsen, M. Amin Khan, Roger A. Kroes, Joseph R. Moskal

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Scopus citations


Study Objectives: The present studies examine the effects of NMDAR activation by NYX-2925 diurnal rhythmicity of both sleep and wake as well as emotion. Methods: Twenty-four-hour sleep EEG recordings were obtained in sleep-deprived and non-sleep-deprived rats. In addition, the day-night cycle of both activity and mood was measured using home cage ultrasonic-vocalization recordings. Results: NYX-2925 significantly facilitated non-REM (NREM) sleep during the lights-on (sleep) period, and this effect persisted for 3 days following a single dose in sleep-deprived rats. Sleep-bout duration and REM latencies were increased without affecting total REM sleep, suggesting better sleep quality. In addition, delta power during wake was decreased, suggesting less drowsiness. NYX-2925 also rescued learning and memory deficits induced by sleep deprivation, measured using an NMDAR-dependent learning task. Additionally, NYX-2925 increased positive affect and decreased negative affect, primarily by facilitating the transitions from sleep to rough-and-tumble play and back to sleep. In contrast to NYX-2925, the NMDAR antagonist ketamine acutely (1-4 hours post-dosing) suppressed REM and non-REM sleep, increased delta power during wake, and blunted the amplitude of the sleep-wake activity rhythm. Discussion: These data suggest that NYX-2925 could enhance behavioral plasticity via improved sleep quality as well as vigilance during wake. As such, the facilitation of sleep by NYX-2925 has the potential to both reduce symptom burden on neurological and psychiatric disorders as well as serve as a biomarker for drug effects through restoration of sleep architecture.

Original languageEnglish (US)
Article numberzsz135
Issue number10
StatePublished - Oct 1 2019


  • EEG
  • Ketamine
  • NMDA receptors
  • Sleep
  • Sleep deprivation
  • Ultrasonic vocalizations

ASJC Scopus subject areas

  • Clinical Neurology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'NMDAR activation regulates the daily rhythms of sleep and mood'. Together they form a unique fingerprint.

  • Cite this

    Burgdorf, J. S., Vitaterna, M. H., Olker, C. J., Song, E. J., Christian, E. P., Sørensen, L., Turek, F. W., Madsen, T. M., Khan, M. A., Kroes, R. A., & Moskal, J. R. (2019). NMDAR activation regulates the daily rhythms of sleep and mood. Sleep, 42(10), [zsz135]. https://doi.org/10.1093/sleep/zsz135